LOADING
Comparing AbbVie Inc (ABBV) and PepsiCo Inc (PEP) across the Health Care and Consumer Staples sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | ABBV | PEP |
|---|---|---|
| Price | $219.68 | $159.88 |
| Change Today | -2.52% | +0.64% |
| Market Cap | $388.4B | $218.6B |
| P/E Ratio | 92.7 | 26.6 |
| Forward P/E | 15.1 | 18.4 |
| PEG Ratio | 0.52 | 3.18 |
| EPS | $2.37 | $6.00 |
| Revenue Growth (YoY) | 10.0% | 5.6% |
| Profit Margin | 6.9% | 8.8% |
| Return on Equity | 62.3% | 42.8% |
| Dividend Yield | 2.95% | 3.54% |
| Beta | 0.33 | 0.38 |
| 52-Week High | $241.12 | $169.96 |
| 52-Week Low | $159.05 | $122.83 |
| Volume | 5.7M | 4.7M |
AbbVie Inc is the larger company by market capitalization. PepsiCo Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. PepsiCo Inc offers a higher dividend yield for income investors. PepsiCo Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.